Vimarsana
Biggest News Aggregation in the World

Edward Pesicka News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Edward Pesicka. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Edward Pesicka Today - Breaking & Trending Today

Trading Day: Local SEC filings for 3.28.24 - Richmond BizSense - Vimarsana News

Trading Day: Local SEC filings for 3.28.24 - Richmond BizSense

Proxy season begins with executive compensation disclosures from Dominion, Owens & Minor and Brink's. Plus, a local REIT buys a hotel in Washington, D.C. (BizSense Pro required)

Owens & Minor, Inc. (NYSE:OMI) Q4 2023 Earnings Call Transcript - Vimarsana News

Owens & Minor, Inc. (NYSE:OMI) Q4 2023 Earnings Call Transcript

Owens & Minor, Inc. (NYSE:OMI) Q4 2023 Earnings Call Transcript February 20, 2024 Owens & Minor, Inc. beats earnings expectations. Reported EPS is $0.69, expectations were $0.68. OMI isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day. And thank […]

Source: yahoo.com
Owens & Minor Shares Jump 23% on 3Q Revenue Growth - Vimarsana News

Owens & Minor Shares Jump 23% on 3Q Revenue Growth

By Denny Jacob Owens & Minor shares were shot up 23% to $19.09 following revenue growth in its latest quarter. The stock, down 2.3% on the year, is on...

Healthcare Logistics Provider Owens & Minor Q3 Results Showcases Resilience But Tightens Annual Outlook - Owens & Minor (NYSE:OMI) - Vimarsana News

Healthcare Logistics Provider Owens & Minor Q3 Results Showcases Resilience But Tightens Annual Outlook - Owens & Minor (NYSE:OMI)

Owens & Minor Inc (NYSE OMI) reported Q3 adjusted EPS of $0.44, up from $0.41 a year ago and beating the consensus of $0.35.

Owens & Minor stock rises on Q2 results - Vimarsana News

Owens & Minor stock rises on Q2 results

Owens & Minor (NYSE:OMI) shares rose today on second-quarter results that included a big three months for its Patient Direct business.